Archive for the ‘CVI’ Category
UGA researchers receive prestigious grant to develop malaria drug
Two University of Georgia researchers have been awarded approximately $770,000 from the Global Health Initiative Technology (GHIT) Fund to develop a new drug to kill the dormant liver stages of Plasmodium vivax, the most widespread of the malaria parasites.
CVM researcher wins $1.1 million grant to study malaria vaccine
Research will be in collaboration with Yale University Chet Joyner, PhD, a faculty member in the Center for Vaccines and Immunology and the Center for Tropical and Emerging Diseases in the College of Veterinary Medicine (CVM) at the University of Georgia, is the recipient of a $1.1 million grant from […]
UGA-led COVID study seeks more applicants
January 2021: In September 2020, the College of Veterinary Medicine announced SPARTA (SARS SeroPrevalence and Respiratory Tract Assessment), a study funded by the NIH National Institute of Allergy and Infectious Diseases and the National Cancer Institute. The study’s original purpose was to investigate the human body’s response to infection with […]
Meet the Faculty: Jarrod Mousa
What is your role at the CVM? When did you come to UGA? I am an assistant professor in the Department of Infectious Diseases. My research laboratory is in the Center for Vaccines and Immunology. I joined UGA in August 2017. What is your research focus? My lab studies antibodies, […]
Engineered dog virus combats coronaviruses
A team of researchers at the University of Georgia College of Veterinary Medicine has developed a COVID-19 vaccine candidate that has proven successful in promoting an immune response in early test models. The team is led by Biao He, the Fred C. Davison Distinguished University Chair in Veterinary Medicine at […]
Staying the Course in the Face of Chaos
It has been a little under a month since COVID-19 was first recognized as a pandemic by the World Health Organization. Around the world, people from all walks of life have been asked to adapt to a new lifestyle—one of constant change and social distancing. Despite the upheaval, the University […]
CVI researchers developing coronavirus vaccine
Ted Ross, director of the CVM’s Center for Vaccines and Immunology, and his team have partnered with labs and biotech companies to develop new vaccines that could protect against the novel coronavirus that causes COVID-19. Learn more here.
Georgia Bio names two College of Veterinary Medicine units as annual Helix Award winners
Two College of Veterinary Medicine units were recently honored at Georgia Bio’s Golden Helix Awards and Annual Gala in Atlanta. The Poultry Diagnostic and Research Center (PDRC) was awarded a Community Award and the Center for Vaccines and Immunology (CVI) received a Deal of the Year Award. The Community Awards […]
CVM faculty member to lead new NIH Collaborative Influenza Vaccine Innovation Center
The University of Georgia has signed a contract with the National Institutes of Health for an initial award of $8 million to develop a new, more advanced influenza vaccine designed to protect against multiple strains of influenza virus in a single dose. The total funding could be up to $130 […]
CVI and Dr. Ted Ross to be featured on Discovery and Science Channel’s new show Invisible Killers
CVI and Dr. Ted Ross to be featured on Discovery and Science Channel’s new show Invisible Killers
UGA Center of Vaccines and Immunology and Sanofi Pasteur extend research collaboration
UGA Center of Vaccines and Immunology and Sanofi Pasteur enter into the next phase of research collaboration.
CVI Welcomes New Director of Partnership Alliances and Business Development for Biomedical Sciences
The Center for Vaccines and Immunology welcomes Dr. Michelle A. Booden as their Director of Partnership Alliances and Business Development for Biomedical Sciences
UGA research team explores impact of age on response to influenza vaccine
UGA research team explores impact of age on response to influenza vaccine
UGA, Sanofi Pasteur develop new broadly protective vaccines for H3N2 influenza
UGA, Sanofi Pasteur develop new broadly protective vaccines for H3N2 influenza
Strong partnership: UGA’s GRA Eminent Scholars foster innovation and economic development
When Dennis Kyle, one of the nation's leading infectious disease researchers, arrived on the University of Georgia campus in January, he became the institution's 17th Georgia Research Alliance Eminent Scholar.
Meet the CVI Team – Karen Norris, PhD
Karen Norris, PhD, GRA Eminent Scholar in Immunology and Translational Biomedical Research and the Wheatley Chair of Immunology.
CVI Officially Open For Business
Commitment, complementary interests help unite 4 researchers toward common goal
